http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-367118-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65505
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-655
filingDate 1969-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1971-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-367118-A1
titleOfInvention A PROCEDURE FOR THE RESOLUTION OF A MIXTURE OF ENANTHTHOMERS OF ACID (CIS-1,2-EPOXYPROPYL) -PHOSPHONIC.
abstract Diastereoisomers of (cis - 1,2 - epoxypropyl) phosphonic (or thiophosphonic) acid derivatives are separated by (a) forming a diastereoisomeric mixture of (1) an ester or amide of (cis- 1,2 - epoxypropyl) - phosphonic (or thiophosphonic) acid containing an optically active ester or amide group or (2) of a salt of an optically active acid or base with an ester or amide of (cis - 1,2 - epoxypropyl)phosphonic or thiophosphonic acid containing a basic or acidic group respectively, the (cis-1,2-epoxypropyl)- phosphonic or thiophosphonic acid residue being present in the diastereoisomeric mixture in both its optically active forms by starting from a mixture of enantiomers of (cis-1,2-epoxypropyl)phosphonic or thiophosphonic acid or a salt or an ester or amide thereof, and (b) separating a diastereoisomer from the diastereoisomeric mixture. The diastereoisomers may be compounds of the formula wherein X is O or S, Y is halo, OR, SR or NRR, and Z is OR1, SR1 or NR1R 1 wherein R is a substituted or unsubstituted hydrocarbyl or heterocyclic group containing an optically active centre and each of R1 and R 1 is H or a substituted or unsubstituted hydrocarbyl or heterocyclic group with the proviso that whenY is halo, R1 is a substituted or unsubstituted hydrocarbyl or heterocyclic group containing an optically active centre. The optically active consituent of the ester group or groups may be derived from an optically active alcohol and the optically active amides may be derived from an optically active primary or secondary amine. The diastereoisomers after separation can be converted to the (+) or (-) enantiomer of cis-1,2-epoxypropyl phosphonic acid or its salts. The individual diastereoisomeric esters can be separated from the mixture thereof by fractional crystallization, chromatography, ion exchange resin procedures or by inclusion or cloth rate compounds. When the diastereoisomers are salts of optically active acids or bases with an ester or amide of (cis-1,2,-epoxypropyl)phosphonic or thiophosphonic acid containing a basic or acidic group respectively the acidic group may be a carboxy, sulphonic, sulphinic, phosphonic or phosphonous acid group and such ester or amide compounds can be prepared (1) by reacting anhydrides (including mono- and dihalides) of (cis-1,2-epoxypropyl) phosphonic acid with strong acids with appropriate alcohols, thio-alcohols, amines, metal alcoholates or thioalcoholates, which also carry an acidic group or a group convertible to an acidic group, (2) by reacting (cis-1,2-epoxypropyl) phosphonic acid or basic salt thereof with an alcohol, thioalcohol or amine carrying such acidic group, or (3) by reacting a metal salt of the phosphonic acid with an appropriate ester of a strong acid (e.g. chloroacetic acid) or with another derivative, the ester or said other derivative also carrying an acidic group or group convertible to an acid group, or (4) by reacting (cis-1,2- epoxypropyl)phosphonic acid or metal salt thereof with alkenes or alkynes in which one of the carbons bearing the unsaturation is also substituted with an electron withdrawing or electronegative atom or group and which also carries an acid group or a group convertible to an acid group. When the diastereoisomers are salts of optically active acids with an ester or amide of (cis-1,2-epoxypropyl) phosphonie acid the said ester or amide may be obtained by a method as in (1) to (4) above but using the corresponding organic reactant containing a basic (e.g. amino) group instead of an acid group. A list of optically active amines (a) and acids (b) suitable for forming the optically acid salts is given and several optically active alcohols (c) and amines (d) suitable for preparing the esters or amides are also specified. In the examples given the optically active amines (a) used include (+) and (-) [alpha]-phenethylamine for (a) and (+) [alpha]-phenethylamine for (d), (+) tartaric acid for (b) and (-) menthol for (c), the ester used in conjunction with the (+) tartaric acid being racemic bis(2-aminoethyl)(cis-1,2-epoxypropyl) phosphonic acid which is obtained by passing racemic monobenzylammonium (cis- 1,2-epoxypropyl) phosphonate in methanol through a strongly acidic ion exchange resin on the H+ cycle, collecting the effluent in pyridine, removing the methanol and then adding ethyleneimine and stirring the mixture at 50 C., the pyridine being finally removed to leave the racemic diester. By using ethylene episulphide instead of ethyleneimine in the above process racemic - bis(2 - mercaptoethyl)(cis - 1,2 - epoxypropyl) phosphonate is obtained which may be reacted with H 2 O 2 and NaHCO 3 in water to form a solution containing racemic disodium (cis - 1,2 - epoxypropyl) - phosphonyl - O,O1- bis(2 - ethylsulphonate) which on treatment with (+) phenethylamine hydrochloride in aqueous solution gives a mixture of diastereoisomeric salts which is recovered by filtering the hot aqueous slurry and the salts then separated by cooling the filtrate to 0 C. and filtering. The following compounds (inter alia) are also prepared in various steps in the examples given: (1) bis-(2-nitroethyl)(-)(cis-1,2-epoxypropyl) phosphonate by adding a solution of sodium nitrate and sodium cobaltinitrate to (cis - 1,2 - epoxypropyl) phosphonyl - O,O1- bis - 2 - ethyl ammonium (+) tartrate (2) N- benzoyl - N - (+) - [alpha] - phenethyl (-) (cis - 1,2- epoxypropyl)-phosphors chloridate from racemic (cis-1,2-epoxypropyl) phosphonic dichloride, (+)-[alpha]-phenethylamine and benzoyl chloride, (3) N - methyl - N(+) - [alpha] - phenethyl - S- ethyl(-)(cis - 1,2 - epoxypropyl) - thiophosphoramidate from the phosphonic dichloride and N-methyl-(+)-[alpha]-phenethylamine with subsequent reaction with potassium ethane thiolate, (4) sodium 2-nitroethyl - (-) (cis - 1,2 - epoxypropyl) phosphonate from sodium nitrite, sodium cobaltinitrite and 2-aminoethyl(-)(cis- 1,2 - epoxypropyl) - phosphonate. The (-)- (cis - 1,2 - epoxypropyl) phosphonic acid and salts thereof obtainable by the invention have antibiotic and antiseptic properties and may be administered orally or parenterally in admixture with suitable diluents and other usual pharmaceutical additives.
priorityDate 1968-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88358
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3014827
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457193621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449704364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4996382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408499458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16666
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20131597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450649535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422762525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408599808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453492911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407907393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16211641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454612640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141233
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11768507
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407330845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415170710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18544691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410541082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553

Total number of triples: 67.